Risk factors in German twins with inflammatory bowel disease: Results of a questionnaire-based survey

Journal of Crohn's and Colitis

Volumn 6, Issue 1, 2012, Pages 29-42

  Spehlmann, Martina E ^a   Begun, Alexander Z ^a   Saroglou, Ekaterini ^b   Hinrichs, Frank ^b   Tiemann, Ute ^b   Raedler, Andreas ^b   Schreiber, Stefan ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Asklepios Westklinikum Hamburg ^*  (Germany)

Author keywords

Crohn's disease; Genetics; Inflammatory bowel disease; Twins; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CONTROLLED STUDY; CROHN DISEASE; DIZYGOTIC TWINS; DRUG USE; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; GASTROINTESTINAL INFECTION; GERMANY; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOZYGOTIC TWINS; PRIORITY JOURNAL; QUESTIONNAIRE; RED MEAT; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; SKIN INFECTION; ULCERATIVE COLITIS; URINARY TRACT INFECTION; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; COLITIS, ULCERATIVE; COMMUNICABLE DISEASES; COMORBIDITY; CROHN DISEASE; DIET; DISEASES IN TWINS; FEMALE; GERMANY; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; YOUNG ADULT;

EID: 84855936107     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.06.007     Document Type: Article

References (71)

1. Tysk C., Lindberg E., Jarnerot G., Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988, 29:990-996.
2. Orholm M., Binder V., Sorensen T.I., Rasmussen L.P., Kyvik K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000, 35:1075-1081.
3. Halfvarson J., Bodin L., Tysk C., Lindberg E., Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003, 124:1767-1773.
4. Thompson N.P., Driscoll R., Pounder R.E., Wakefield A.J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996, 312:95-96.
5. Spehlmann M.E., Begun A.Z., Burghardt J., Lepage P., Raedler A., Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008, 14:968-976.
6. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
7. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
8. Hampe J., Frenzel H., Mirza M.M., Croucher P.J., Cuthbert A., Mascheretti S., Huse K., Platzer M., Bridger S., Meyer B., Nurnberg P., Stokkers P., Krawczak M., Mathew C.G., Curran M., Schreiber S. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A 2002, 99:321-326.
9. Stoll M., Corneliussen B., Costello C.M., Waetzig G.H., Mellgard B., Koch W.A., Rosenstiel P., Albrecht M., Croucher P.J., Seegert D., Nikolaus S., Hampe J., Lengauer T., Pierrou S., Foelsch U.R., Mathew C.G., Lagerstrom-Fermer M., Schreiber S. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004, 36:476-480.
10. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., Newman B., Van Oene M., Cescon D., Greenberg G., Griffiths A.M., St George-Hyslop P.H., Siminovitch K.A. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004, 36:471-475.
11. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
12. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., De La Vega F.M., Briggs J., Gunther S., Prescott N.J., Onnie C.M., Hasler R., Sipos B., Folsch U.R., Lengauer T., Platzer M., Mathew C.G., Krawczak M., Schreiber S. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39:207-211.
13. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., Domingues F.S., Albrecht M., Nothnagel M., Ellinghaus D., Sina C., Onnie C.M., Weersma R.K., Stokkers P.C., Wijmenga C., Gazouli M., Strachan D., McArdle W.L., Vermeire S., Rutgeerts P., Rosenstiel P., Krawczak M., Vatn M.H., Mathew C.G., Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
14. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
15. Rutgeerts P., D'Haens G., Hiele M., Geboes K., Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994, 106:1251-1253.
16. Radford-Smith G.L., Edwards J.E., Purdie D.M., Pandeya N., Watson M., Martin N.G., Green A., Newman B., Florin T.H. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002, 51:808-813.
17. Radford-Smith G.L. What is the importance of appendectomy in the natural history of IBD?. Inflamm Bowel Dis 2008, 14(Suppl 2):S72-S74.
18. Logan R.F., Edmond M., Somerville K.W., Langman M.J. Smoking and ulcerative colitis. Br Med J (Clin Res Ed) 1984, 288:751-753.
19. Thornton J.R., Emmett P.M., Heaton K.W. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985, 290:1786-1787.
20. Riordan A.M., Ruxton C.H., Hunter J.O. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998, 52:229-238.
21. Mayberry J.F., Rhodes J., Allan R., Newcombe R.G., Regan G.M., Chamberlain L.M., Wragg K.G. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981, 26:444-448.
22. Tragnone A., Valpiani D., Miglio F., Elmi G., Bazzocchi G., Pipitone E., Lanfranchi G.A. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995, 7:47-51.
23. Reif S., Klein I., Lubin F., Farbstein M., Hallak A., Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997, 40:754-760.
24. Shoda R., Matsueda K., Yamato S., Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996, 63:741-745.
25. Geerling B.J., Dagnelie P.C., Badart-Smook A., Russel M.G., Stockbrugger R.W., Brummer R.J. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000, 95:1008-1013.
26. Tjonneland A., Overvad K., Bergmann M.M., Nagel G., Linseisen J., Hallmans G., Palmqvist R., Sjodin H., Hagglund G., Berglund G., Lindgren S., Grip O., Palli D., Day N.E., Khaw K.T., Bingham S., Riboli E., Kennedy H., Hart A. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009, 58:1606-1611.
27. Jantchou P., Morois S., Clavel-Chapelon F., Boutron-Ruault M.C., Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol 2010, 105:2195-2201.
28. Wakefield A.J., Sawyerr A.M., Hudson M., Dhillon A.P., Pounder R.E. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991, 36:1147-1150.
29. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., Gendre J.P. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999, 45:218-222.
30. Godet P.G., May G.R., Sutherland L.R. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995, 37:668-673.
31. Garcia Rodriguez L.A., Ruigomez A., Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006, 130:1588-1594.
32. Halfvarson J., Jess T., Magnuson A., Montgomery S.M., Orholm M., Tysk C., Binder V., Jarnerot G. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006, 12:925-933.
33. Miner P.B. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997, 92:1S-4S.
34. Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., Targan S.R. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002, 123:689-699.
35. Cederlof R., Friberg L., Jonsson E., Kaij L. Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet Stat Med 1961, 11:338-362.
36. Radon K., Windstetter D., Poluda A.L., Mueller B., von Mutius E., Koletzko S. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics 2007, 120:354-361.
37. Amre D.K., Lambrette P., Law L., Krupoves A., Chotard V., Costea F., Grimard G., Israel D., Mack D., Seidman E.G. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006, 101:1005-1011.
38. Yanai-Kopelman D., Paz A., Rippel D., Potasman I. Inflammatory bowel disease in returning travelers. J Travel Med 2000, 7:333-335.
39. Danese S., Sans M., Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004, 3:394-400.
40. Van Kruiningen H.J., Joossens M., Vermeire S., Joossens S., Debeugny S., Gower-Rousseau C., Cortot A., Colombel J.F., Rutgeerts P., Vlietinck R. Environmental factors in familial Crohn's disease in Belgium. Inflamm Bowel Dis 2005, 11:360-365.
41. Persson P.G., Ahlbom A., Hellers G. Crohn's disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand J Gastroenterol 1987, 22:385-389.
42. Persson P.G., Ahlbom A., Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992, 3:47-52.
43. Gilat T., Hacohen D., Lilos P., Langman M.J. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987, 22:1009-1024.
44. Boyko E.J., Perera D.R., Koepsell T.D., Keane E.M., Inui T.S. Coffee and alcohol use and the risk of ulcerative colitis. Am J Gastroenterol 1989, 84:530-534.
45. Tilg H., Kaser A. Diet and relapsing ulcerative colitis: take off the meat?. Gut 2004, 53:1399-1401.
46. Jowett S.L., Seal C.J., Pearce M.S., Phillips E., Gregory W., Barton J.R., Welfare M.R. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004, 53:1479-1484.
47. Singh S., Graff L.A., Bernstein C.N. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?. Am J Gastroenterol 2009, 104:1298-1313. quiz 1314.
48. Wakefield A.J., Montgomery S.M. Measles virus as a risk for inflammatory bowel disease: an unusually tolerant approach. Am J Gastroenterol 2000, 95:1389-1392.
49. Davis R.L., Bohlke K. Measles vaccination and inflammatory bowel disease: controversy laid to rest?. Drug Saf 2001, 24:939-946.
50. Bernstein C.N., Rawsthorne P., Blanchard J.F. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:759-762.
51. Bernstein C.N., Wajda A., Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005, 129:827-836.
52. Balan V., LaRusso N.F. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol Clin North Am 1995, 24:647-669.
53. Shah S.A., Peppercorn M.A., Pallotta J.A. Autoimmune (Hashimoto's) thyroiditis associated with Crohn's disease. J Clin Gastroenterol 1998, 26:117-120.
54. Bardella M.T., Elli L., De Matteis S., Floriani I., Torri V., Piodi L. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Ann Med 2009, 41:139-143.
55. Gran J.T., Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn's disease. Dig Dis 1992, 10:274-294.
56. Bourikas L.A., Papadakis K.A. Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1915-1924.
57. Karolyi Z., Eros N., Ujszaszy L., Nagy G. Cutaneous and mucosal manifestations of inflammatory bowel diseases. Orv Hetil 2000, 141:1391-1395.
58. Levine J.B., Lukawski-Trubish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am 1995, 24:633-646.
59. Rhew E.Y., Ramsey-Goldman R., Buchman A.L. Sjogren's syndrome in association with Crohn's disease. J Clin Gastroenterol 2003, 37:312-314.
60. Palm O., Moum B., Gran J.T. Estimation of Sjogren's syndrome among IBD patients. A six year post-diagnostic prevalence study. Scand J Rheumatol 2002, 31:140-145.
61. Warren S., Sommers S.C. Pathogenesis of ulcerative colitis. Am J Pathol 1949, 25:657-679.
62. Kruschewski M., Buhr H.J. The vasculitis in IBD is associated with the degree of inflammation. Dig Dis Sci 2010, 55:733-738.
63. Raj A.A., Birring S.S., Green R., Grant A., de Caestecker J., Pavord I.D. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008, 102:780-785.
64. Kurina L.M., Goldacre M.J., Yeates D., Seagroatt V. Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health 2002, 56:551-554.
65. Gearry R.B., Richardson A.K., Frampton C.M., Dodgshun A.J., Barclay M.L. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010, 25:325-333.
66. Vind I., Riis L., Jespersgaard C., Jess T., Knudsen E., Pedersen N., Elkjaere M., Hansen T.S., Andersen I.B., Paerregaard A., Bondesen S., Locht H., Larsen S.O., Moesgaard F., Bendtsen F., Andersen P.S., Munkholm P. Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. J Crohns Colitis 2008, 2:162-169.
67. Joffe N. Roentgenologic abnormalities of the urinary bladder secondary to Crohn's disease. AJR Am J Roentgenol 1976, 127:297-302.
68. Fraser J.S., Muller A.F., Smith D.J., Newman D.J., Lamb E.J. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment Pharmacol Ther 2001, 15:1131-1137.
69. Kreisel W., Wolf L.M., Grotz W., Grieshaber M. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996, 8:461-468.
70. Porter C.K., Tribble D.R., Aliaga P.A., Halvorson H.A., Riddle M.S. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008, 135:781-786.
71. Gradel K.O., Nielsen H.L., Schonheyder H.C., Ejlertsen T., Kristensen B., Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009, 137:495-501.